Next Hurdles For COVID-19 Vaccine Development: Selecting Endpoints, Getting Enough Subjects

 
• By Brenda Sandburg
  
COVID-19 Vaccine. Corona Virus SARS-CoV-2, 2019 nCoV virus destruction. A vaccine against coronavirus disease 2019. Breakthrough in the Creating of a COVID-19 Vaccine.
COVID-19 vaccine candidates face new challenges as they move into Phase 2/3 trials
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet